Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Authors = Nazanin Alaghemand

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
7 pages, 1032 KiB  
Review
Analysis of the Delta Variant B.1.617.2 COVID-19
by Shayan Shiehzadegan, Nazanin Alaghemand, Michael Fox and Vishwanath Venketaraman
Clin. Pract. 2021, 11(4), 778-784; https://doi.org/10.3390/clinpract11040093 - 21 Oct 2021
Cited by 226 | Viewed by 14963
Abstract
With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As [...] Read more.
With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As of August 2021, the delta variant has quickly become the dominant strain. Despite countries like the US, where most of the population is vaccinated, COVID-19 has made a resurgence in infections. Collectively, as a country, we ask: is it more deadly? What makes it more “contagious” or “transmissible”? This review article delves into the information we already know about the delta variant and how it compares with the other SARS-CoV-2 variants. The current vaccine companies like AstraZeneca, Pfizer/BioNTech, and Moderna have reported that their vaccines can provide protection against this variant but with a slightly reduced efficacy. In this article, we do a comprehensive review and summary of the delta B.1.617.2 variant and what makes it more contagious. Full article
Show Figures

Figure 1

Back to TopTop